IntoCell, Inc. (KOSDAQ:287840)
South Korea flag South Korea · Delayed Price · Currency is KRW
66,200
-4,800 (-6.76%)
At close: Dec 5, 2025

IntoCell Statistics

Total Valuation

IntoCell has a market cap or net worth of KRW 982.91 billion. The enterprise value is 962.69 billion.

Market Cap 982.91B
Enterprise Value 962.69B

Important Dates

Earnings Date n/a
Ex-Dividend Date n/a

Share Statistics

IntoCell has 14.85 million shares outstanding. The number of shares has increased by 6.06% in one year.

Current Share Class 14.85M
Shares Outstanding 14.85M
Shares Change (YoY) +6.06%
Shares Change (QoQ) +5.75%
Owned by Insiders (%) 22.29%
Owned by Institutions (%) 9.56%
Float 11.39M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 583.85
PB Ratio 40.82
P/TBV Ratio 49.68
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -92.16
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF -133.20

Financial Position

The company has a current ratio of 8.06, with a Debt / Equity ratio of 0.42.

Current Ratio 8.06
Quick Ratio 8.03
Debt / Equity 0.42
Debt / EBITDA n/a
Debt / FCF -1.41
Interest Coverage -40.22

Financial Efficiency

Return on equity (ROE) is -62.07% and return on invested capital (ROIC) is -24.47%.

Return on Equity (ROE) -62.07%
Return on Assets (ROA) -20.17%
Return on Invested Capital (ROIC) -24.47%
Return on Capital Employed (ROCE) -28.30%
Revenue Per Employee n/a
Profits Per Employee n/a
Employee Count n/a
Asset Turnover 0.05
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

Beta (5Y) n/a
52-Week Price Change n/a
50-Day Moving Average 51,554.00
200-Day Moving Average n/a
Relative Strength Index (RSI) 59.35
Average Volume (20 Days) 919,156

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, IntoCell had revenue of KRW 1.68 billion and -10.45 billion in losses. Loss per share was -755.25.

Revenue 1.68B
Gross Profit 1.68B
Operating Income -10.56B
Pretax Income -10.45B
Net Income -10.45B
EBITDA -9.86B
EBIT -10.56B
Loss Per Share -755.25
Full Income Statement

Balance Sheet

The company has 30.44 billion in cash and 10.22 billion in debt, giving a net cash position of 20.22 billion or 1,361.69 per share.

Cash & Cash Equivalents 30.44B
Total Debt 10.22B
Net Cash 20.22B
Net Cash Per Share 1,361.69
Equity (Book Value) 24.08B
Book Value Per Share 1,631.75
Working Capital 27.50B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -7.08 billion and capital expenditures -144.35 million, giving a free cash flow of -7.23 billion.

Operating Cash Flow -7.08B
Capital Expenditures -144.35M
Free Cash Flow -7.23B
FCF Per Share -486.76
Full Cash Flow Statement

Margins

Gross Margin 99.56%
Operating Margin -627.37%
Pretax Margin -620.51%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

IntoCell does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -6.06%
Shareholder Yield -6.06%
Earnings Yield -1.06%
FCF Yield -0.74%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

IntoCell has an Altman Z-Score of 14.31 and a Piotroski F-Score of 3.

Altman Z-Score 14.31
Piotroski F-Score 3